HARMONIE PHARMA
The computed 12-month bankruptcy probability of HARMONIE PHARMA is 1.3% (low). The 2024 annual accounts show equity of €297k and a net result of €-230k. Equity is growing by ~11% per year across the filed fiscal years. Its solvency ranks better than 94% of 6720 sector peers (fiscal year 2024). The company has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €297k |
| Net result | €-230k |
| Better than sector | 94% |
| Active | 28 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 82.9% | 20.4% | |
| Net result | €-230k | €4k | |
| Equity | €297k | €16k | |
| Gross operating margin | €-59k | €24k | |
| Staff costs | €63k | €33k |
Show 15 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €-128k |
| Net profit | €-230k |
| Cash flow | €-222k |
| Staff costs | €63k |
| Income taxes | €96k |
| Dividends | - |
| Total assets | €358k |
| Equity | €297k |
| Debt | €61k |
| of which ≤ 1y | €61k |
| of which > 1y | €0 |
| Working capital | €268k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 5.38 |
| Quick ratio | 3.74 |
| Working capital ratio | 74.8% |
| Solvency | 82.9% |
| Debt / equity | 0.21 |
| Long-term debt ratio | 0.00 |
| Interest coverage | -58.40 |
| Gross margin | - |
| Net margin | - |
| ROA | -64.2% |
| ROE | -77.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (25 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €358k |
| Fixed assets | 21/28 | €29k |
| Tangible fixed assets | 22/27 | €26k |
| Financial fixed assets | 28 | €4k |
| Current assets | 29/58 | €329k |
| Stocks & contracts in progress | 3 | €101k |
| Amounts receivable within one year | 40/41 | €63k |
| Cash & bank | 54/58 | €59k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €358k |
| Equity | 10/15 | €297k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €2k |
| Accumulated profits (losses) | 14 | €277k |
| Amounts payable | 17/49 | €61k |
| Amounts payable after one year | 17 | €0 |
| Amounts payable within one year | 42/48 | €61k |
| Trade debts payable within one year | 44 | €54k |
| Income statement | ||
| Gross operating margin | 9900 | €-59k |
| Operating result | 9901 | €-135k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €-134k |
| Income taxes | 67/77 | €96k |
| Net result for the period | 9904 | €-230k |
| Result to be appropriated | 9905 | €-230k |
-
GROUPE TETE PHARMACEUTICALLegal entityDirector· perm. rep.: Tete KwassiganState Gazette act 26050304 (17-04-2026)Current17-04-2026 → present
Historic, not recently confirmed (2)
-
Novesta bvbaLegal entityManager· perm. rep.: Him OMARState Gazette act 17084344 (16-06-2017)Not recently confirmedlast confirmed in an act from 2017
-
Not recently confirmedlast confirmed in an act from 2016
Former directors (4)
-
Former18-07-2016 → 01-06-2017
2 events
- 01-06-2017 Resigned· Manager
- 18-07-2016 Mandate renewed· Manager
-
Former- → 30-06-2016
-
Former31-05-2016 → 30-06-2016
2 events
- 30-06-2016 Resigned· Manager
- 31-05-2016 Appointed· Manager
-
Former31-05-2016 → 30-06-2016
2 events
- 30-06-2016 Resigned· Manager
- 31-05-2016 Appointed· Manager
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 30-10-1997 |
| Status | Active |
| Postal code | 1000 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21812N0980/00D000 | Brussels | 3,679 m² | 1 · 979 m² | 25.4 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 11 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
20-05-2026 General meeting · Name change · Statute amendment · Power of attorney
- Filing: 2026-05-18 · PHARMA YSER
- General meeting: 2026-05-08 · PHARMA YSER
- Name change: HARMONIE PHARMA · PHARMA YSER
- Statute amendment: article 1 · PHARMA YSER
- Power of attorney: faire le nécessaire pour la coordination des statuts · PHARMA YSER
- Notarial deed: 2026-05-08 · PHARMA YSER
- Publication: 2026-05-20
- Act object: BENAMING
Technical details
{
"facts": [
{
"type": "filing",
"quote": "Neergelegd 18-05-2026",
"value": "2026-05-18",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Par devant le Notaire Jonathan Flameng, de r\u00E9sidence \u00E0 Ch\u00E2telet, en date du 8 mai 2026, S\u0027est r\u00E9unie l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e \u0022PHARMA YSER\u0022",
"value": "2026-05-08",
"object": null,
"subject": "e1"
},
{
"type": "name_change",
"quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de modifier la d\u00E9nomination actuelle en \u0022HARMONIE PHARMA\u0022.",
"value": "HARMONIE PHARMA",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de modifier l\u0027article 1 des statuts pour l\u0027adapter \u00E0 la pr\u00E9sente modification de la d\u00E9nomination.",
"value": "article 1",
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u2019assembl\u00E9e donne tous pouvoirs \u00E0 l\u2019administrateur pour faire le n\u00E9cessaire pour la coordination des statuts.",
"value": "faire le n\u00E9cessaire pour la coordination des statuts",
"object": "e5",
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Par devant le Notaire Jonathan Flameng, de r\u00E9sidence \u00E0 Ch\u00E2telet, en date du 8 mai 2026",
"value": "2026-05-08",
"object": "e2",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 20/05/2026",
"value": "2026-05-20",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Onderwerp akte : BENAMING",
"value": "BENAMING",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 3459,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0461.800.766",
"kind": "company",
"name": "PHARMA YSER",
"attrs": {
"seat": "Lakensestraat 129, 1000 Brussel",
"new_name": "HARMONIE PHARMA",
"legal_form": "Besloten Vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Jonathan Flameng",
"attrs": {
"role": "Notaire"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Kwassigan (dit \u00AB Aim\u00E9 \u00BB) TETE",
"attrs": {
"role": "pr\u00E9sident"
}
},
{
"id": "e4",
"kbo": "0542.600.182",
"kind": "company",
"name": "Groupe Tete Pharmaceutical SRL",
"attrs": {
"role": "actionnaire unique",
"seat": "1400 Nivelles, rue de l\u0027\u00E9v\u00EAch\u00E9 8"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "TETE Kwassigan Tsonyuido",
"attrs": {
"role": "administrateur",
"address": "rue Saint-George 33 \u00E0 1400 Nivelles"
}
}
]
}17-04-2026 Act object · General meeting · Officer resignation · Officer discharge
- Filing: 2026-04-10 · PHARMA YSER
- Publication: 2026-04-17 · PHARMA YSER
- Act object: Ontslag - Benoeming · PHARMA YSER
- General meeting: 2026-04-01 · PHARMA YSER
- Officer resignation: role: bestuurder · Crown Consultancy BV
- Officer resignation: role: permanent vertegenwoordiger · Crown Consultancy BV
- Officer resignation: role: permanent vertegenwoordiger · Him Omar
- Officer discharge · Him Omar
- Officer appointment: role: bestuurder · GROUPE TETE PHARMACEUTICAL BV
- Permanent representative: role: Vaste Vertegenwoordiger · Tete Kwassigan
- Board meeting · PHARMA YSER
- Officer appointment: role: bestuurder · GROUPE TETE PHARMACEUTICAL BV
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · MBM Groupe BV
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Thierry Graulich
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Christophe Dereume
- Power of attorney: purpose: afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank · Isabelle De Roose
Technical details
{
"facts": [
{
"type": "filing",
"quote": "neergelegd/ontvangen op 10 APR. 2026",
"value": "2026-04-10",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 17/04/2026",
"value": "2026-04-17",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte: Ontslag - Benoeming",
"value": "Ontslag - Benoeming",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "De notulen van de buitengewone algemene vergadering van Pharma Yser BV, gehouden op 1 april 2026",
"value": "2026-04-01",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als bestuurder",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als permanent vertegenwoordiger",
"value": {
"role": "permanent vertegenwoordiger"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_resignation",
"quote": "De Algemene Vergadering aanvaardt het ontslag van Crown Consultancy BV (BE0749.592.244) ... als permanent vertegenwoordiger, de heer Him Omar",
"value": {
"role": "permanent vertegenwoordiger"
},
"object": "e1",
"subject": "e4"
},
{
"type": "officer_discharge",
"quote": "De Algemene Vergadering aanvaardt unaniem zijn ontslag en verleent hem voorlopige kwijting voor het beheer tot die datum",
"value": null,
"object": "e1",
"subject": "e4"
},
{
"type": "officer_appointment",
"quote": "De Algemene Vergadering benoemt GROUPE TETE PHARMACEUTICAL BV (KBO 0542.600.182) ... tot bestuurder.",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e5"
},
{
"type": "permanent_representative",
"quote": "De heer Tete Kwassigan ... wordt hierbij, v\u00F3\u00F3r de ondertekening van dit document, benoemd tot Vaste Vertegenwoordiger van GROUPE TETE PHARMACEUTICAL BV om de bovengenoemde functies uit te oefenen.",
"value": {
"role": "Vaste Vertegenwoordiger"
},
"object": "e5",
"subject": "e6"
},
{
"type": "board_meeting",
"quote": "De nieuw samengestelde Raad van Bestuur vergaderde vervolgens.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "GROUPE TETE PHARMACEUTICAL BV (BE0542.600.182) ... wordt benoemd tot bestuurder.",
"value": {
"role": "bestuurder"
},
"object": "e1",
"subject": "e5"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e7"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e8"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e9"
},
{
"type": "power_of_attorney",
"quote": "De vergadering machtigt MBM Groupe BV ... vertegenwoordigd door de heer Thierry Graulich en/of de heer Christophe Dereume en/of mevrouw Isabelle De Roose, voor het afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank.",
"value": {
"purpose": "afhandelen van de betreffende formaliteiten bij de griffie van de Handelsrechtbank"
},
"object": "e1",
"subject": "e10"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2448,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0461.800.766",
"kind": "company",
"name": "PHARMA YSER",
"attrs": {
"seat": "Lakensestraat 129 - 1000 Brussel",
"legal_form": "Besloten vennootschap"
}
},
{
"id": "e2",
"kbo": "0749.592.244",
"kind": "company",
"name": "Crown Consultancy BV",
"attrs": {
"seat": "Maria van Hongarijselaan 22, 1083 Ganshoren"
}
},
{
"id": "e3",
"kbo": "0568.541.447",
"kind": "company",
"name": "Novesta BV",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Him Omar",
"attrs": {}
},
{
"id": "e5",
"kbo": "0542.600.182",
"kind": "company",
"name": "GROUPE TETE PHARMACEUTICAL BV",
"attrs": {
"seat": "Rue de l\u0027Evech\u00E9 8, 1400 Nivelles"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Tete Kwassigan",
"attrs": {}
},
{
"id": "e7",
"kbo": "0542.637.202",
"kind": "company",
"name": "MBM Groupe BV",
"attrs": {
"seat": "Avenue Tedesco 7, 1160 Oudergem, Belgi\u00EB"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Thierry Graulich",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Christophe Dereume",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Isabelle De Roose",
"attrs": {}
}
]
}12-07-2024 Him Omar reappointed as director
- Him Omar, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Him Omar",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0568541447",
"name": "Novesta",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de sa nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e : - La soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u0022Novesta\u0022, dont le si\u00E8ge social est \u00E9tabli \u00E0 "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "BELLIPHARMA YSER",
"legal_form": "BVBA"
}
}16-06-2017 1 director appointed, 1 resigning
- Him OMAR, Zaakvoerder
- Shilan OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Shilan OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2017-06-01",
"evidence_quote": "Te ontslaan als zaakvoerder en dit met ingang vanaf 01/06/2017: mevrouw Shilan OMAR, gedomicilieerd te Jetselaan 58- 1081 Koekelberg."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Him OMAR",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Novesta bvba",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2017-06-01",
"evidence_quote": "Te benoemen tot zaakvoerder en dit met ingang vanaf 01/06/2017 en voor onbepaaide duur: Novesta bvba, met zetel te Wereldtentoonstellingslaan 7/B10, 1083 Brussel, vertegenwoordigd door de heer Him OMAR als vaste vertegenwoordiger van Novesta bvba."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "BELLIPHARMA YSER",
"legal_form": "BVBA"
}
}21-09-2016 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": false,
"effective_date": "2016-09-02",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}18-07-2016 1 director appointed, 3 resigning, 1 reappointed
- Lazgin OTHMAN, Zaakvoerder
- Him OMAR, Zaakvoerder
- Isolde BLONDELLE, Zaakvoerder
- Noshin OMAR, Zaakvoerder
- Shilan OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Him OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Meneer Him OMAR, gedomicilieerd te Wereldtentoonstellingslaan 7/B10 - 1083 Ganshoren, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Isolde BLONDELLE",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Mevrouw Isolde BLONDELLE, gedomicilleerd te Wereldtentoonstellingslaan 7/B10-1083 Ganshoren, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Noshin OMAR",
"address": null,
"birth_date": null
},
"effective_date": "2016-06-30",
"evidence_quote": "De algemene vergadering aanvaardt het ontslag van Meneer Noshin OMAR, gedomicilieerd te Gouden Leeuwstraat 17-9300 Aalst, als zaakvoerder en dit met onmiddelijke ingang.",
"discharge_granted": true
},
{
"kind": "director_renew",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Shilan OMAR",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering hernieuwt het mandaat van Mevrouw Shilan OMAR, gedomicilieerd te Jetselaan 58-1081 Koekelberg, als zaakvoerder en dit voor onbepaalde duur."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Lazgin OTHMAN",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Meneer Lazgin OTHMAN, gedomicilieerd te Jetselaan 58 - 1081 Koekelberg, tot zaakvoerder en dit voor onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
}
}31-05-2016 2 directors appointed
- Isolde BLONDELLE, Zaakvoerder
- Noshin OMAR, Zaakvoerder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Isolde BLONDELLE",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Mevrouw Isolde BLONDELLE, gedomicilieerd Wereldtentoonstellingslaan 7/B10 te 1083 Ganshoren, tot zaakvoerder en dit voor een onbepaalde duur."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Noshin OMAR",
"address": null,
"birth_date": null
},
"evidence_quote": "De algemene vergadering benoemt Meneer Noshin OMAR, gedomicilieerd te Gouden Leeuwstraat 17, 9300 Aalst, tot zaakvoerder en dit voor een onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0461.800.766",
"name_full": "PHARMACIE MALFAIT-BOTBOL",
"legal_form": "BVBA"
}
}| Legal nameNL | HARMONIE PHARMA |
| Legal nameNL | PHARMA YSER |